Production (Stage)
Zimmer Biomet Holdings, Inc.
ZBH
$92.64
$0.971.06%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 1.05% | 4.28% | 4.03% | 3.87% | 3.18% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 1.05% | 4.28% | 4.03% | 3.87% | 3.18% |
Cost of Revenue | 7.32% | 10.03% | 2.37% | 5.29% | 2.30% |
Gross Profit | -1.28% | 2.12% | 4.72% | 3.32% | 3.51% |
SG&A Expenses | 3.06% | 2.88% | 5.03% | 0.89% | 3.20% |
Depreciation & Amortization | 6.26% | 8.76% | 2.21% | 4.20% | 6.52% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 4.78% | 5.49% | 3.03% | 2.08% | 2.78% |
Operating Income | -13.17% | 0.49% | 8.82% | 11.35% | 4.72% |
Income Before Tax | 6.51% | 1.62% | 5.06% | 9.22% | -25.00% |
Income Tax Expenses | 9.93% | 136.17% | -133.51% | -11.66% | -21.81% |
Earnings from Continuing Operations | 5.67% | -42.77% | 53.04% | 15.87% | -25.74% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -50.00% | -40.00% | 0.00% | -50.00% | -100.00% |
Net Income | 5.57% | -42.87% | 53.10% | 15.84% | -25.85% |
EBIT | -13.17% | 0.49% | 8.82% | 11.35% | 4.72% |
EBITDA | -5.69% | 3.48% | 6.69% | 7.80% | 4.04% |
EPS Basic | 8.90% | -40.34% | 58.10% | 17.48% | -24.33% |
Normalized Basic EPS | -16.07% | 3.75% | 13.41% | 16.51% | 4.31% |
EPS Diluted | 8.33% | -40.51% | 59.74% | 18.00% | -24.32% |
Normalized Diluted EPS | -15.99% | 3.68% | 13.62% | 16.84% | 4.30% |
Average Basic Shares Outstanding | -3.07% | -4.23% | -3.16% | -1.39% | -2.01% |
Average Diluted Shares Outstanding | -3.15% | -4.17% | -3.33% | -1.67% | -2.00% |
Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | -0.08% | 0.67% | -0.36% | -0.15% | 0.32% |